Dong-dong Wu

发表

Genetic landscape of recurrent ASXL1, U2AF1, SF3B1, SRSF2, and EZH2 mutations in 304 Chinese patients with myelodysplastic syndromes

Saijuan Chen, Lanping Xu, Xiao Li, 2016, Tumor Biology.

Exploration of the role of gene mutations in myelodysplastic syndromes through a sequencing design involving a small number of target genes

Xiao Li, Chun-kang Chang, Feng Xu, 2017, Scientific Reports.

A genetic development route analysis on MDS subset carrying initial epigenetic gene mutations

Xiao Li, Chun-kang Chang, Feng Xu, 2020, Scientific Reports.

Bone Marrow Fibrosis at Diagnosis and during the Course of Disease Is Associated with TP53 Mutations and Adverse Prognosis in Primary Myelodysplastic Syndrome

Sida Zhao, Zheng Zhang, Chun-kang Chang, 2022, Cancers.

Integration Analysis of JAK2 or RUNX1 Mutation With Bone Marrow Blast Can Improve Risk Stratification in the Patients With Lower Risk Myelodysplastic Syndrome

Chun-kang Chang, Juan Guo, Lingyun Wu, 2021, Frontiers in Oncology.

Rigosertib as a selective anti-tumor agent can ameliorate multiple dysregulated signaling transduction pathways in high-grade myelodysplastic syndrome

Ling Wu, Yang Zhu, Xiao Li, 2014, Scientific Reports.

Establishment and Validation of an Updated Diagnostic FCM Scoring System Based on Pooled Immunophenotyping in CD34+ Blasts and Its Clinical Significance for Myelodysplastic Syndromes

Yang Zhu, Xiao Li, Chun-kang Chang, 2014, PloS one.

Iron overload promotes mitochondrial fragmentation in mesenchymal stromal cells from myelodysplastic syndrome patients through activation of the AMPK/MFF/Drp1 pathway

Sida Zhao, Xiao Li, Chun-kang Chang, 2018, Cell Death & Disease.

Dynamics of epigenetic regulator gene BCOR mutation and response predictive value for hypomethylating agents in patients with myelodysplastic syndrome

Xiao Li, Chun-kang Chang, Juan Guo, 2021, Clinical Epigenetics.

Lenalidomide restores the osteogenic differentiation of bone marrow mesenchymal stem cells from multiple myeloma patients via deactivating Notch signaling pathway.

Sida Zhao, Xiao Li, Chun-kang Chang, 2017, Oncotarget.

Decitabine treatment sensitizes tumor cells to T-cell-mediated cytotoxicity in patients with myelodysplastic syndromes.

Xiao Li, Chun-kang Chang, Juan Guo, 2017, American journal of translational research.

Cellular senescence induced by S100A9 in mesenchymal stromal cells through NLRP3 inflammasome activation

Yan Jia, Chun-kang Chang, Juan Guo, 2019, Aging.

TP53 mutations predict decitabine‐induced complete responses in patients with myelodysplastic syndromes

Xiao Li, Chun-kang Chang, Juan Guo, 2017, British journal of haematology.

Whole-exome and targeted sequencing identify ROBO1 and ROBO2 mutations as progression-related drivers in myelodysplastic syndromes

Yang Zhu, Xiao Li, Chun-kang Chang, 2015, Nature Communications.

AHR signaling pathway reshapes the metabolism of AML/MDS cells and potentially leads to cytarabine resistance.

Yan Jia, Chun-kang Chang, Juan Guo, 2021, Acta biochimica et biophysica Sinica.

Iron overload promotes mitochondrial fragmentation in mesenchymal stromal cells from myelodysplastic syndrome patients through activation of the AMPK/MFF/Drp1 pathway

Sida Zhao, Xiao Li, Chun-kang Chang, 2018, Cell Death & Disease.

Dicer1 downregulation by multiple myeloma cells promotes the senescence and tumor-supporting capacity and decreases the differentiation potential of mesenchymal stem cells

Sida Zhao, Xiao Li, Chun-kang Chang, 2018, Cell Death & Disease.

Cytogenetic response based on revised IPSS cytogenetic risk stratification and minimal residual disease monitoring by FISH in MDS patients treated with low-dose decitabine.

Xiao Li, Chun-kang Chang, Lingyun Wu, 2013, Leukemia research.

The efficacy and toxicity of the CHG priming regimen (low-dose cytarabine, homoharringtonine, and G-CSF) in higher risk MDS patients relapsed or refractory to decitabine

Xiao Li, Chun-kang Chang, Y. Tao, 2019, Journal of Cancer Research and Clinical Oncology.

Decitabine of Reduced Dosage in Chinese Patients with Myelodysplastic Syndrome: A Retrospective Analysis

Q. Song, M. Hou, Xiao Li, 2014, PloS one.

Cytogenetic Response Based On Revised IPSS Cytogenetic Risk Stratification and Minimal Residual Disease Monitoringby FISH In MDS Patients Treated By Low-Dose Decitabine

Chun-kang Chang, Lingyun Wu, Dong-dong Wu, 2013 .

Modulation of A2a receptor antagonist on D2 receptor internalization and ERK phosphorylation

Lei Zhang, Dong-dong Wu, Lin-yin Feng, 2013, Acta Pharmacologica Sinica.

Dicer1 downregulation by multiple myeloma cells promotes the senescence and tumor-supporting capacity and decreases the differentiation potential of mesenchymal stem cells

Sida Zhao, Xiao Li, Chun-kang Chang, 2018, Cell Death & Disease.

High expression of the human equilibrative nucleoside transporter 1 gene predicts a good response to decitabine in patients with myelodysplastic syndrome

Xiao Li, Chun-kang Chang, Wenhui Shi, 2016, Journal of Translational Medicine.

Phosphorylation stabilized TET1 acts as an oncoprotein and therapeutic target in B cell acute lymphoblastic leukemia

Yanhong Shi, Jingling Xue, Xiwei Wu, 2022, Science Translational Medicine.

Increased PD-1/STAT1 ratio may account for the survival benefit in decitabine therapy for lower risk myelodysplastic syndrome

Xiao Li, Chun-kang Chang, Juan Guo, 2017, Leukemia & lymphoma.

Change in microbial community in landfill refuse contaminated with antibiotics facilitates denitrification more than the increase in ARG over long-term

B. Xie, Xiaojun Zhang, Kailiang Yang, 2017, Scientific Reports.

Lenalidomide restores the osteogenic differentiation of bone marrow mesenchymal stem cells from multiple myeloma patients via deactivating Notch signaling pathway

Sida Zhao, Xiao Li, Chun-kang Chang, 2017, OncoTarget.

A genetic development route analysis on MDS subset carrying initial epigenetic gene mutations

Xiao Li, Chun-kang Chang, Juan Guo, 2020, Scientific Reports.

Down-regulation of Dicer1 promotes cellular senescence and decreases the differentiation and stem cell-supporting capacities of mesenchymal stromal cells in patients with myelodysplastic syndrome

Yang Zhu, Xiao Li, Chun-kang Chang, 2015, Haematologica.

LLDT-67 attenuates MPTP-induced neurotoxicity in mice by up-regulating NGF expression

Linyin Feng, Lei Zhang, Dong-dong Wu, 2012, Acta Pharmacologica Sinica.

QKI shuttles internal m7G-modified transcripts into stress granules and modulates mRNA metabolism

Jingling Xue, Chao Shen, R. Su, 2023, Cell.

High expression of the human equilibrative nucleoside transporter 1 gene predicts a good response to decitabine in patients with myelodysplastic syndrome

Qi He, Feng Xu, Lingyun Wu, 2016, Journal of Translational Medicine.

Incorporating mutations and bone marrow fibrosis into the revised international prognostic scoring system in myelodysplastic syndromes

Juan Guo, Dong-dong Wu, Youshan Zhao, 2023, Leukemia & lymphoma.

Efficacy and toxicity of decitabine versus CHG regimen (low-dose cytarabine, homoharringtonine and granulocyte colony-stimulating factor) in patients with higher risk myelodysplastic syndrome: a retrospective study

Xiao Li, Chun-kang Chang, Lingyun Wu, 2016, Leukemia & lymphoma.

Whole-exome and targeted sequencing identify ROBO1 and ROBO2 mutations as progression-related drivers in myelodysplastic syndromes

Yang Zhu, Xiao Li, Chun-kang Chang, 2015, Nature Communications.

NPM1 mutation with DNMT3A wild type defines a subgroup of MDS with particularly favourable outcomes after decitabine therapy

Xiao Li, Chun-kang Chang, Juan Guo, 2020, British Journal of Haematology.

Phosphorylation stabilized TET1 acts as an oncoprotein and therapeutic target in B cell acute lymphoblastic leukemia

Yanhong Shi, Jingling Xue, Xiwei Wu, 2023, Science Translational Medicine.